Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
NCT00002148 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2005-06-24
Summary
To assess the tolerability and safety of OPC-14117. To evaluate effects of OPC-14117 on cognitive function, quality of life, and activities of daily living.
Conditions
- Cognitive Disorders
- HIV Infections
Interventions
- DRUG
-
OPC 14117
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
NCT00002288 ·Status: COMPLETED ·Phase: NA
-
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy
NCT04266002 ·Status: COMPLETED ·Phase: NA
-
Mental Ability Challenge Study in Adults With and Without HIV
NCT03244488 ·Status: COMPLETED
-
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
NCT01665846 ·Status: COMPLETED ·Phase: PHASE1
-
Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
NCT01108679 ·Status: COMPLETED
-
Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
NCT01340950 ·Status: COMPLETED ·Phase: PHASE4
-
Research on the Psychological Status of Patients With HIV-1 Infection
NCT07080138 ·Status: NOT_YET_RECRUITING
-
Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
NCT00002209 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
NCT00737204 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
NCT00001048 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Decreased Mental Function Associated With HIV
NCT00027040 ·Status: COMPLETED ·Phase: NA
-
Effects of Anti-HIV Therapy on Nervous System Function
NCT00432003 ·Status: COMPLETED
-
An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
NCT00000709 ·Status: COMPLETED ·Phase: PHASE3
-
Antiplatelet Therapy in HIV
NCT02559414 ·Status: COMPLETED ·Phase: PHASE2
-
The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
NCT00540137 ·Status: COMPLETED ·Phase: PHASE4
-
Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
NCT01600170 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828 ·Status: COMPLETED ·Phase: PHASE2
-
Maraviroc and NeuroAIDS Pathogenesis
NCT02159027 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Glucocorticoids on Cognition in HIV-infected Women
NCT03237689 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Galantamine on Inflammation and Cognition
NCT03384784 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
NCT02592174 ·Status: COMPLETED ·Phase: NA
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
Baricitinib for Reduction of HIV - CNS
NCT05452564 ·Status: RECRUITING ·Phase: PHASE2
-
Suppression of HIV 1 RNA in People Living With HIV
NCT02363387 ·Status: COMPLETED ·Phase: NA
-
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
NCT00000393 ·Status: COMPLETED ·Phase: PHASE1